{"id":525490,"date":"2021-08-09T12:57:18","date_gmt":"2021-08-09T16:57:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/"},"modified":"2021-08-09T12:57:18","modified_gmt":"2021-08-09T16:57:18","slug":"axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/","title":{"rendered":"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Aug.  09, 2021  (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton is investigating Axsome Therapeutics, Inc. (NASDAQ: AXSM) for potential securities law violations. Investors who have lost money in their Axsome Therapeutics investment should\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ATiWf4rM8xMQYfAku1mk0l_UyV8zyg6StwIamcCcf_07WrAdvsuTBM09JPKQNvrHB6d3Bj04M_wVikz2O6Wf0GmBHM9--mridh12I-fBj7g=\" rel=\"nofollow noopener\" target=\"_blank\"><u>contact the firm<\/u><\/a>\u00a0to learn more about how they might recover those losses. For more details, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NsxfwfjfSzWhAHsNL5UKQ5HRhpAeSGHe05kbRKYkETXG9crCo5rIzLVxzAtJ8qq39YxpYR7IocFi2HGvATLXGdKUKHJRjtFh8yCpcB_8qAOnn6zdRo285gz0E9zXCEjbBFEctYE6ubK_0vBWEQ5Ahg==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.blockleviton.com\/cases\/axsm<\/a>.<\/p>\n<p>\n        <strong>What is this all about?<\/strong>\n      <\/p>\n<p>Before the market opened on August 9, 2021, Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) had identified deficiencies in their review of Axsome\u2019s New Drug Application (NDA) for AXS-05. The Company said it is attempting to learn the nature of the discrepancies in order to address them, but said the development may lead to a delay in the potential approval of AXS-05.<\/p>\n<p>On this news shares of Axsome stock fell 40% in intraday trading.<\/p>\n<p>\n        <strong>Who is eligible?<\/strong>\n      <\/p>\n<p>Anyone who purchased Axsome Therapeutics stock and has lost money as a result of this news may be eligible, whether or not they have sold their investment. Investors should contact Block &amp; Leviton to learn more.<\/p>\n<p>\n        <strong>What is Block &amp; Leviton doing?<\/strong>\n      <\/p>\n<p>Block &amp; Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.<\/p>\n<p>\n        <strong>What should you do next?<\/strong>\n      <\/p>\n<p>If you&#8217;ve lost money on your investment, you should contact Block &amp; Leviton to learn more via our\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dQn_Yz35DB4UvhjbbjGfOvafart0_W50ShQkMlNI3myWy-E8oLdr4gEr7LWPivpCesiZAe6MGgv-AyFp8DyxzAjFrW1bV5SJRmEop5jTeME=\" rel=\"nofollow noopener\" target=\"_blank\"><u>case website<\/u><\/a>, by email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3EyntXI0G4XDCda9alvRE3ZIJBCu1ReU6RFaE9raT3ZXDzrcZlssyupZsAAisuiTzR3LydmOXbJKUDfH1V4gtNCYfMsHRqFFPZl4AdsBV70=\" rel=\"nofollow noopener\" target=\"_blank\"><u>cases@blockleviton.com<\/u><\/a>, or by phone at (617) 398-5600.<\/p>\n<p>\n        <strong>Why should you contact Block &amp; Leviton?<\/strong>\n      <\/p>\n<p>Many law firms have issued releases about this matter; most of those firms do not actually litigate securities class actions. Block &amp; Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation&#8217;s top institutional investors hire us to represent their interests. You can learn more about us at our website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wks06Z0GYQGT7YxLJyKOqsDvVH6dRft5XhQH4VkSFgt19gEygM8XHHaCsTaZn0WxjH_i1545JZOjIGtLv7Mix-nF38nXEzuiNJuM7QEsp7Y=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.blockleviton.com<\/u><\/a>, or call (617) 398-5600 or email cases@blockleviton.com with any questions.<\/p>\n<p>This notice may constitute attorney advertising.<\/p>\n<p>CONTACT:<br \/>BLOCK &amp; LEVITON LLP<br \/>260 Franklin St., Suite 1860<br \/>Boston, MA 02110<br \/>Phone: (617) 398-5600<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3EyntXI0G4XDCda9alvRE3ZIJBCu1ReU6RFaE9raT3aR5TFuS40ml19PB0V4Hmek0sqSrkMASw8DBME93HttxUhBRio-X_anOYy_kPkehBs=\" rel=\"nofollow noopener\" target=\"_blank\"><u>cases@blockleviton.com<\/u><\/a>\u00a0<\/p>\n<p>SOURCE: Block &amp; Leviton LLP<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wks06Z0GYQGT7YxLJyKOqr9JycXme_bcjz2rjIEKXkO93KfzcbKW8ty9uvvVXHaL08rBmhgvrWogkUk-aw014WYRvKcgkd8damwqgxOo8M8=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.blockleviton.com<\/u><\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjA2MjVhNzYtNTRjNS00ZWU4LWE0NTUtMjQyZDhhYjgyNjE4LTEwMjk2OTA=\/tiny\/Block-Leviton-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Aug. 09, 2021 (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton is investigating Axsome Therapeutics, Inc. (NASDAQ: AXSM) for potential securities law violations. Investors who have lost money in their Axsome Therapeutics investment should\u00a0contact the firm\u00a0to learn more about how they might recover those losses. For more details, visit\u00a0https:\/\/www.blockleviton.com\/cases\/axsm. What is this all about? Before the market opened on August 9, 2021, Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) had identified deficiencies in their review of Axsome\u2019s New Drug Application (NDA) for AXS-05. The Company said it is attempting to learn the nature of the discrepancies in order to address them, but said the development may lead to a delay in the potential approval of AXS-05. On &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-525490","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Aug. 09, 2021 (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton is investigating Axsome Therapeutics, Inc. (NASDAQ: AXSM) for potential securities law violations. Investors who have lost money in their Axsome Therapeutics investment should\u00a0contact the firm\u00a0to learn more about how they might recover those losses. For more details, visit\u00a0https:\/\/www.blockleviton.com\/cases\/axsm. What is this all about? Before the market opened on August 9, 2021, Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) had identified deficiencies in their review of Axsome\u2019s New Drug Application (NDA) for AXS-05. The Company said it is attempting to learn the nature of the discrepancies in order to address them, but said the development may lead to a delay in the potential approval of AXS-05. On &hellip; Continue reading &quot;AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-09T16:57:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm\",\"datePublished\":\"2021-08-09T16:57:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/\"},\"wordCount\":398,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/\",\"name\":\"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=\",\"datePublished\":\"2021-08-09T16:57:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Market Newsdesk","og_description":"BOSTON, Aug. 09, 2021 (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton is investigating Axsome Therapeutics, Inc. (NASDAQ: AXSM) for potential securities law violations. Investors who have lost money in their Axsome Therapeutics investment should\u00a0contact the firm\u00a0to learn more about how they might recover those losses. For more details, visit\u00a0https:\/\/www.blockleviton.com\/cases\/axsm. What is this all about? Before the market opened on August 9, 2021, Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) had identified deficiencies in their review of Axsome\u2019s New Drug Application (NDA) for AXS-05. The Company said it is attempting to learn the nature of the discrepancies in order to address them, but said the development may lead to a delay in the potential approval of AXS-05. On &hellip; Continue reading \"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-09T16:57:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm","datePublished":"2021-08-09T16:57:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/"},"wordCount":398,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/","name":"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=","datePublished":"2021-08-09T16:57:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNTU3NyM0MzQ4OTMwIzIwMTgxMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-investigation-block-leviton-investigates-axsome-therapeutics-for-potential-securities-law-violations-investors-who-have-lost-money-are-encouraged-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AXSOME THERAPEUTICS INVESTIGATION: Block &amp; Leviton Investigates Axsome Therapeutics For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/525490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=525490"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/525490\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=525490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=525490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=525490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}